MBT
PFE icon

Monroe Bank & Trust’s Pfizer PFE Stock Holding History

Monroe Bank & Trust’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.4M Sell
33,985
-4,767
-12% -$189K 0.47% 39
2019
Q1 		$1.56M Sell
38,752
-1,816
-4% -$72.7K 0.5% 31
2018
Q4 		$1.68M Sell
40,568
-1,636
-4% -$67.9K 0.56% 26
2018
Q3 		$1.76M Sell
42,204
-3,056
-7% -$118K 0.54% 30
2018
Q2 		$1.56M Sell
45,260
-800
-2% -$27.3K 0.48% 35
2018
Q1 		$1.55M Sell
46,060
-1,639
-3% -$56.3K 0.49% 33
2017
Q4 		$1.64M Buy
47,699
+506
+1% +$17.3K 0.51% 34
2017
Q3 		$1.6M Buy
47,193
+214
+0.5% +$6.88K 0.53% 34
2017
Q2 		$1.5M Sell
46,979
-796
-2% -$25.1K 0.5% 35
2017
Q1 		$1.55M Sell
47,775
-650
-1% -$20.5K 0.51% 34
2016
Q4 		$1.49M Sell
48,425
-132
-0.3% -$4.03K 0.51% 36
2016
Q3 		$1.46M Sell
48,557
-5,300
-10% -$177K 0.53% 36
2016
Q2 		$1.8M Sell
53,857
-807
-1% -$25.8K 0.62% 33
2016
Q1 		$1.54M Sell
54,664
-468
-0.8% -$13.4K 0.53% 40
2015
Q4 		$1.69M Sell
55,132
-612
-1% -$19.3K 0.61% 38
2015
Q3 		$1.66M Sell
55,744
-248
-0.4% -$7.95K 0.61% 36
2015
Q2 		$1.78M Sell
55,992
-2,017
-3% -$65.7K 0.6% 41
2015
Q1 		$1.92M Sell
58,009
-1,653
-3% -$52.6K 0.66% 39
2014
Q4 		$1.76M Buy
59,662
+444
+0.7% +$12.7K 0.6% 42
2014
Q3 		$1.66M Sell
59,218
-1,413
-2% -$39.7K 0.61% 42
2014
Q2 		$1.71M Buy
60,631
+2,553
+4% +$72.8K 0.56% 42
2014
Q1 		$1.77M Buy
58,078
+13,024
+29% +$388K 0.59% 45
2013
Q4 		$1.31M Buy
45,054
+1,338
+3% +$38.9K 0.51% 56
2013
Q3 		$1.19M Buy
43,716
+4,859
+13% +$132K 0.49% 59
2013
Q2 		$1.03M Buy
+38,857
New +$1.07M 0.46% 62

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Monroe Bank & Trust's PFE Position: Q2 2019 in Review

Monroe Bank & Trust reduced its Pfizer (PFE) stake by 12% in Q2 2019, selling an estimated $189K and leaving 33,985 shares worth $1.4M. The position accounts for 0.47% of the portfolio, ranked #39.

Monroe Bank & Trust first reported a position in PFE in Q2 2013 and has held it in 25 quarters since. The position peaked at $1.92M in Q1 2015. 2,377 funds tracked by Wall St. Rank hold PFE as of Q2 2019.

  • Monroe Bank & Trust held 33,985 shares of Pfizer worth $1.4M as of Q2 2019.
  • Monroe Bank & Trust sold 4,767 Pfizer shares in Q2 2019, an estimated $189K.
  • Pfizer made up 0.47% of Monroe Bank & Trust's portfolio in Q2 2019, its #39 holding.
  • Monroe Bank & Trust first reported a position in Pfizer in Q2 2013 and has held it in 25 quarters since.
  • Monroe Bank & Trust's Pfizer position peaked at $1.92M in Q1 2015.
  • 2,377 funds tracked by Wall St. Rank held Pfizer as of Q2 2019.

Based on Monroe Bank & Trust's 13F filing for Q2 2019, filed 29 Jul 2019.